Assignee
EPIMAB BIOTHERAPEUTICS INC
CN·3 granted patents·4 pending applications·26 citations·filing 2016–2024
Top patents by PatentIndex Score
7 records- 0195US10266608B2Fabs-in-tandem immunoglobulin and uses thereofEPIMAB BIOTHERAPEUTICS INC·Filed 2016·Granted Apr 23, 2019·23 cites·12 claims
- 0285US11421028B2Fabs-in-tandem immunoglobulin and uses thereofEPIMAB BIOTHERAPEUTICS INC·Filed 2017·Granted Aug 23, 2022·3 cites·6 claims
- 0375US2024409668A1Monovalent asymmetric tandem fab bispecific antibodiesEPIMAB BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0471US2023132403A9Fabs-in-tandem immunoglobulin and uses thereofEPIMAB BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0569US12540185B2Fabs-in-tandem immunoglobulin and uses thereofEPIMAB BIOTHERAPEUTICS INC·Filed 2022·Granted Feb 3, 2026·0 cites·14 claims
- 0669US2020157249A1Fabs-in-tandem immunoglobulin and uses thereofEPIMAB BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0751US2019177439A1Monovalent Asymmetric Tandem Fab Bispecific AntibodiesEPIMAB BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EPIMAB BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →